0.7000GBp0.00%Mkt Cap: 3.17M GBpP/E: —Last update: 2026-06-01
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Swit…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.17M GBp
Enterprise Value1.87M GBp
Revenue (TTM)1.01M GBp
Gross Profit-513.08K GBp
Net Income (TTM)-415.25K GBp
Revenue/Share0.0030 GBp
Last Price0.7000 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA-3.56
EV/Revenue1.85
P/S3.15
P/B7.00
EPS (TTM)0.00
EPS (Forward)-0.34
52W Range
0.253082% of range0.8000
52W High0.8000 GBp
52W Low0.2530 GBp
Profitability
Gross Margin-50.89%
Oper. Margin-61.93%
EBITDA Margin-51.91%
Profit Margin-52.97%
ROE-59.99%
ROA-46.55%
Growth
Revenue Growth49.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-546.14K GBp
CapEx (TTM)3.94K GBp
FCF Margin-31.45%
FCF Yield-9.99%
Net Debt-257.00K GBp
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity—
Current Ratio3.30
Quick Ratio3.30
Book Value/Sh0.0010 GBp
Cash/Share0.0010 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateDec 19, 2016
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.453.21M
Float220.77M
Insiders20.61%
Institutions1.20%
Technical
SMA 500.5181 (+35.1%)
SMA 2000.4355 (+60.7%)
Beta0.95
S&P 52W Chg27.94%
Avg Vol (30d)7.91M
Avg Vol (10d)7.21M
Technical Indicators
RSI (14)70.3
MACD0.0476
MACD Signal0.0364
MACD Hist.+0.0111
BB Upper0.7273 GBp
BB Middle0.5850 GBp
BB Lower0.4427 GBp
BB Width48.65%
ATR (14)0.0872 GBp
Vol Ratio (20d)0.90x